We are live on
!
Find out more
SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
92 hedge funds and large institutions have $1.78B invested in SpringWorks Therapeutics in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 4
22% more capital invested
Capital invested by funds: $1.46B → $1.78B (+$317M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
18% more funds holding
Funds holding: 78 → 92 (+14)
6.2% more ownership
Funds ownership: 80.93% → 87.13% (+6.2%)
3% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 30
Holders
92
Holders Change
+14
Holders Change %
+17.95%
% of All Funds
1.86%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
18
Increased
29
Reduced
30
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$9.92M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7.07M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$6.79M |
| 4 |
Millennium Management
New York
|
-$5.66M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$4.62M |
